Table 1

Clinical outcomes during the acute phase of management

All patients*HVILVIP value
No of patients20776122
LOS, days, median (IQR)9 (3–18)14 (4–24)8 (3–15)<0.001
LOS/TBSA, days/%, median (IQR)2 (1–4)3 (1–8)2 (1–3)<0.001
TBSA, %, median (IQR)4 (1–10)3 (1–15)5 (2–9)0.44
No of ORs, median (IQR)1 (0–2)2 (0–3)0 (0–1)<0.001
Complications, no (%)
 Rhabdomyolysis9 (4)9 (12)0 (0)<0.001
 Compartment syndrome17 (8)12 (16)5 (4)0.007
 Infection28 (14)15 (20)11 (9)0.05
 Sepsis11 (5)8 (11)3 (2)0.02
 Multiple organ failure1 (0)1 (1)0 (0)0.38
 Amputation26 (13)21 (28)3 (2)<0.001
 Multiple amputations13 (6)10 (13)2 (2)0.001
Requiring rehabilitation, no. (%)106 (51)49 (64)54 (44)0.008
 Discharged to inpatient rehabilitation, no (%)†34 (32)22 (45)10 (19)0.005
 Discharged to outpatient rehabilitation, no (%)†72 (68)27 (55)44 (81)0.005
Mortality, no (%)4 (2)3 (4)1 (1)0.16
  • *Includes patients whose voltage was not otherwise specified (n=9).

  • †Percentages are calculated based on the total number of patients requiring any form of rehabilitation (all patients, n=106; HVI, n=49; LVI, n=54).

  • HVI, high-voltage injury; LOS, length of stay; LVI, low-voltage injury; TBSA, total body surface area.